Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Gerald Watts

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Vascular Endothelium

Concepts & Ideas

Kinetics

Procedures

Double-Blind Method

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
67
Barrett, Hugh
62
Chan, Dick
18
Burke, Valerie
18
Ooi, Esther
16
Redgrave, Trevor
16
Beilin, Lawrence
14
Mori, Trevor
13
Mamo, John
11
Naoumova, Rossi
11
Sönksen, Peter
11
Thompson, Gilbert
10
Puddey, Ian
10
Stuckey, Bronwyn
10
Ng, Theodore
10
Playford, David

Sign-in to see all Coauthors

Publications

TOP 3
Ng Theodore W K; Chan Dick C; Barrett P Hugh R; Watts Gerald F
Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.
Chan Dick C; Lambert Gilles; Barrett P Hugh R; Rye Kerry-Anne; Ooi Esther M M; Watts Gerald F
Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism?
Chan Dick C; Watts Gerald F; Ooi Esther M M; Rye Kerry-Anne; Ji Juying; Johnson Anthony G; Barrett P Hugh R
Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Gerald Watts (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Ng Theodore W K; Chan Dick C; Barrett P Hugh R; Watts Gerald F
Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.
Clinical science (London, England : 1979) 2010;118(1):79-85.
2009: Chan Dick C; Lambert Gilles; Barrett P Hugh R; Rye Kerry-Anne; Ooi Esther M M; Watts Gerald F
Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism?
Clinical chemistry 2009;55(11):2049-52.
2009: Chan Dick C; Watts Gerald F; Ooi Esther M M; Rye Kerry-Anne; Ji Juying; Johnson Anthony G; Barrett P Hugh R
Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome.
Diabetes care 2009;32(11):2111-3.
2009: Mori Trevor A; Burke Valerie; Puddey Ian; Irish Ashley; Cowpland Christine A; Beilin Lawrence; Dogra Gursharan; Watts Gerald F
The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial.
Journal of hypertension 2009;27(9):1863-72.
2009: Ooi Esther M M; Ng Theodore W K; Chan Dick C; Watts Gerald F
Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes.
Diabetes research and clinical practice 2009;85(3):310-6.
2009: Watts Gerald F; Ooi Esther M M; Chan Dick C
Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo.
Pharmacology & therapeutics 2009;123(3):281-91.
2009: Watts Gerald F; Hamilton-Craig Ian; Sullivan David R
NICE guidance on familial hypercholesterolaemia: all sugar and spice?
Heart, lung & circulation 2009;18(3):181-3.
2009: Hamilton Sandra J; Chew Gerard T; Watts Gerald F
Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.
Diabetes care 2009;32(5):810-2.
2009: Chan Dick C; Barrett P Hugh R; Ooi Esther M M; Ji Juying; Chan Doris T; Watts Gerald F
Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
The Journal of clinical endocrinology and metabolism 2009;94(3):989-97.
2008: Ooi Esther M M; Watts Gerald F
Nutrition and metabolism: new insights into lifestyle modifications and pharmacotherapy for managing cardiometabolic risk.
Current opinion in lipidology 2008;19(6):617-9.
2008: Gan Seng Khee; Adams Leon A; Watts Gerald F
The trials and tribulations of the treatment of nonalcoholic fatty-liver disease.
Current opinion in lipidology 2008;19(6):592-9.
2008: Jones Michelle R; Wilson Scott G; Mullin Ben H; Mead Robert; Dudbridge Frank; Watts Gerald F; Stuckey Bronwyn G A
Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome.
Fertility and sterility 2008;90(6):2298-303.
2008: Chan D C; Watts G F; Ng T W K; Yamashita S; Barrett P H R
Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
European journal of clinical investigation 2008;38(10):743-51.
2008: Cussons Andrea J; Watts Gerald F; Burke Valerie; Shaw Jonathan E; Zimmet Paul Z; Stuckey Bronwyn G A
Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
Human reproduction (Oxford, England) 2008;23(10):2352-8.
2008: Chan Dick C; Watts Gerald F; Ooi Esther M M; Ji Juying; Johnson Anthony G; Barrett P Hugh R
Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(10):1831-7.
2008: Bates Timothy R; Burnett John R; van Bockxmeer Frank M; Hamilton Sandra; Arnolda Leonard; Watts Gerald F
Detection of familial hypercholesterolaemia: a major treatment gap in preventative cardiology.
Heart, lung & circulation 2008;17(5):411-3.
2008: Watts Gerald F; Barrett P Hugh R; Chan Dick C
HDL metabolism in context: looking on the bright side.
Current opinion in lipidology 2008;19(4):395-404.
2008: Ooi Esther M M; Watts Gerald F; Chan Dick C; Chen Meifania M; Nestel Paul J; Sviridov Dmitri; Barrett P Hugh R
Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome.
Diabetes care 2008;31(8):1656-61.
2008: Chew Gerard T; Watts Gerald F; Davis Timothy M E; Stuckey Bronwyn G A; Beilin Lawrence J; Thompson Peter L; Burke Valerie; Currie Philip J
Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction.
Diabetes care 2008;31(8):1502-9.
2008: Chan Dick C; Watts Gerald F; Wang Jian; Hegele Robert A; van Bockxmeer Frank M; Barrett P Hugh R
Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men.
Clinical endocrinology 2008;69(1):45-51.
2008: Ooi Esther M M; Barrett P Hugh R; Chan Dick C; Watts Gerald F
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.
Clinical science (London, England : 1979) 2008;114(10):611-24.
2008: Chan D C; Chen M M; Ooi E M M; Watts G F
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
International journal of clinical practice 2008;62(5):799-809.
2008: Gan Seng Khee; Watts Gerald F
Is adipose tissue lipolysis always an adaptive response to starvation?: implications for non-alcoholic fatty liver disease.
Clinical science (London, England : 1979) 2008;114(8):543-5.
2008: Ooi Esther M M; Barrett P Hugh R; Chan Dick C; Nestel Paul J; Watts Gerald F
Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome.
Atherosclerosis 2008;197(1):139-46.
2008: Watts Gerald F; Gan Seng Khee
Nutrition and metabolism: non-alcoholic fatty liver disease - pathogenesis, cardiovascular risk and therapy.
Current opinion in lipidology 2008;19(1):92-4.
2008: Ooi Esther M M; Watts Gerald F; Nestel Paul J; Sviridov Dmitri; Hoang Anh; Barrett P Hugh R
Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome.
The Journal of clinical endocrinology and metabolism 2008;93(2):430-7.
2008: Chan Dick C; Nguyen Minh N; Watts Gerald F; Barrett P Hugh R
Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.
The Journal of clinical endocrinology and metabolism 2008;93(2):557-64.
2008: Chan Doris T; Irish Ashley B; Dogra Gursharan K; Watts Gerald F
Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials.
Atherosclerosis 2008;196(2):823-34.
2008: Hooper A J; Crawford G M; Brisbane J M; Robertson K; Watts G F; van Bockxmeer F M; Burnett J R
Familial lipoprotein lipase deficiency caused by known (G188E) and novel (W394X) LPL gene mutations.
Annals of clinical biochemistry 2008;45(Pt 1):102-5.
2008: Chan Dick C; Watts Gerald F
Pharmacological regulation of dyslipoproteinaemia in insulin resistant states.
Current vascular pharmacology 2008;6(1):67-77.
2007: Ng Theodore W K; Watts Gerald F; Barrett P Hugh R; Rye Kerry-Anne; Chan Dick C
Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels.
Diabetes care 2007;30(11):2945-50.
2007: Stuckey Bronwyn G A; Walsh John P; Ching Helena L; Stuckey Alexander W; Palmer Neil R; Thompson Peter L; Watts Gerald F
Erectile dysfunction predicts generalised cardiovascular disease: evidence from a case-control study.
Atherosclerosis 2007;194(2):458-64.
2007: Watts Gerald F; Lewis Barry; Sullivan David R
Familial hypercholesterolemia: a missed opportunity in preventive medicine.
Nature clinical practice. Cardiovascular medicine 2007;4(8):404-5.
2007: Hamilton Sandra J; Chew Gerard T; Watts Gerald F
Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2007;4(2):89-102.
2007: Jones M R; Wilson S G; Mullin B H; Mead R; Watts G F; Stuckey B G A
Polymorphism of the follistatin gene in polycystic ovary syndrome.
Molecular human reproduction 2007;13(4):237-41.
2007: Cussons Andrea J; Stuckey Bronwyn G A; Watts Gerald F
Metabolic syndrome and cardiometabolic risk in PCOS.
Current diabetes reports 2007;7(1):66-73.
2007: Burnett John R; Watts Gerald F
MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?
Expert opinion on therapeutic targets 2007;11(2):181-9.
2007: Ooi Esther M M; Watts Gerald F; Barrett P Hugh R; Chan Dick C; Clifton Peter M; Ji Juying; Nestel Paul J
Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.
Asia Pacific journal of clinical nutrition 2007;16(4):624-31.
2007: Potter Kathleen; Green Daniel J; Reed Christopher J; Woodman Richard J; Watts Gerald F; McQuillan Brendan M; Burke Valerie; Hankey Graeme J; Arnolda Leonard F
Carotid intima-medial thickness measured on multiple ultrasound frames: evaluation of a DICOM-based software system.
Cardiovascular ultrasound 2007;5():29.
2006: Ooi Esther M M; Watts Gerald F; Ji Juying; Rye Kerry-Anne; Johnson Anthony G; Chan Dick C; Barrett P Hugh R
Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo.
Clinical endocrinology 2006;65(6):752-9.
2006: Jones Michelle R; Italiano Lisa; Wilson Scott G; Mullin Ben H; Mead Robert; Dudbridge Frank; Watts Gerald F; Stuckey Bronwyn G A
Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome.
Fertility and sterility 2006;86(5):1438-46.
2006: Chan D C; Watts G F; Ng T W K; Hua J; Song S; Barrett P H R
Measurement of liver fat by magnetic resonance imaging: Relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men.
Diabetes, obesity & metabolism 2006;8(6):698-702.
2006: Chew Gerard T; Gan Seng Khee; Watts Gerald F
Revisiting the metabolic syndrome.
The Medical journal of Australia 2006;185(8):445-9.
2006: Watts G F; Chan D C; Ooi E M M; Nestel P J; Beilin L J; Barrett P H R
Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies.
Clinical and experimental pharmacology & physiology 2006;33(9):877-82.
2006: Ooi E M M; Watts G F; Farvid M S; Chan D C; Allen M C; Zilko S R; Barrett P H R
High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.
European journal of clinical investigation 2006;36(9):626-32.
2006: Watts Gerald F; Ji Juying; Chan Dick C; Ooi Esther M M; Johnson Anthony G; Rye Kerry-Anne; Barrett P Hugh R
Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome.
Clinical science (London, England : 1979) 2006;111(3):193-9.
2006: Barrett P Hugh R; Chan Dick C; Watts Gerald F
Thematic review series: patient-oriented research. Design and analysis of lipoprotein tracer kinetics studies in humans.
Journal of lipid research 2006;47(8):1607-19.
2006: Chan Dick C; Watts Gerald F; Nguyen Minh N; Barrett P Hugh R
Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity.
The American journal of clinical nutrition 2006;84(1):37-43.
2006: Allister E M; James A P; Watts G F; Barrett P H R; Mamo J C L
Effect of an acute hyperinsulinaemic clamp on post-prandial lipaemia in subjects with insulin resistance.
European journal of clinical investigation 2006;36(7):489-96.
2006: Nguyen Minh N; Chan Dick C; Dwyer Kevin P; Bolitho Paul; Watts Gerald F; Barrett P Hugh R
Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma.
Journal of lipid research 2006;47(6):1274-80.
2006: Chan D C; Watts G F
Apolipoproteins as markers and managers of coronary risk.
QJM : monthly journal of the Association of Physicians 2006;99(5):277-87.
2006: Cussons Andrea J; Stuckey Bronwyn G A; Watts Gerald F
Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
Atherosclerosis 2006;185(2):227-39.
2006: Chan Dick C; Watts Gerald F; Nguyen Minh N; Barrett P Hugh R
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(3):590-6.
2006: Ji Juying; Watts Gerald F; Johnson Anthony G; Chan Dick C; Ooi Esther M M; Rye Kerry-Anne; Serone Adrian P; Barrett P Hugh R
High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics.
The Journal of clinical endocrinology and metabolism 2006;91(3):973-9.
2006: Chan Dick C; Barrett P Hugh R; Watts Gerald F
Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders.
Current opinion in lipidology 2006;17(1):28-36.
2006: Woodman Richard J; Playford David A; Watts Gerald F
Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol.
Diabetes research and clinical practice 2006;71(1):59-67.
2006: Chan Dick C; Watts Gerald F
Recent advances in the investigation of lipoprotein metabolism using tracer methodology.
Clinical laboratory 2006;52(7-8):353-61.
2005: Ng T W K; Watts G F; Stuckey B G A; Ching H L; Chan D C F; Uchida Y; Sakai N; Yamashita S; Martins I J; Redgrave T G; Barrett P H R
Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
Clinical endocrinology 2005;63(6):650-6.
2005: Woodman R J; Watts G F; Playford D A; Best J D; Chan D C
Oxidized LDL and small LDL particle size are independently predictive of a selective defect in microcirculatory endothelial function in type 2 diabetes.
Diabetes, obesity & metabolism 2005;7(5):612-7.
2005: Chan Dick C; Watts Gerald F; Ng Theodore W K; Uchida Yoshiaki; Sakai Naohiko; Yamashita Shizuya; Barrett P Hugh R
Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
Clinical biochemistry 2005;38(9):806-12.
2005: Farvid M S; Ng T W K; Chan D C; Barrett P H R; Watts G F
Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia.
Diabetes, obesity & metabolism 2005;7(4):406-13.
2005: James A P; Watts G F; Mamo J C L
The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects.
Diabetes, obesity & metabolism 2005;7(4):381-9.
2005: Hunter Michael; Angelicheva Dora; Tournev Ivailo; Ingley Evan; Chan Dick C; Watts Gerald F; Kremensky Ivo; Kalaydjieva Luba
NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24.
Biochemical and biophysical research communications 2005;332(4):982-92.
2005: Ooi Esther M M; Watts Gerald F; Farvid Maryam S; Chan Dick C; Allen Michael C; Zilko Simon R; Barrett P Hugh R
High-density lipoprotein apolipoprotein A-I kinetics in obesity.
Obesity research 2005;13(6):1008-16.
2005: Ng Theodore W K; Watts Gerald F; Farvid Maryam S; Chan Dick C; Barrett P Hugh R
Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics?
Diabetes 2005;54(3):795-802.
2005: Dogra G K; Watts G F; Chan D C; Stanton K
Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(3):239-42.
2005: Chan Dick C; Watts Gerald F; Ng Theodore W K; Uchida Yoshiaki; Sakai Naohiko; Yamashita Shizuya; Barrett P Hugh R
Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism.
Clinical chemistry 2005;51(3):578-85.
2005: Woodman Richard J; Chew Gerard T; Watts Gerald F
Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.
Drugs 2005;65(1):31-74.
2004: Chan D C; Watts G F
LDL heterogeneity revisited: lesson for the metabolic syndrome from a new interpopulation study?
European journal of clinical investigation 2004;34(11):719-22.
2004: Chan D C; Watts G F; Barrett P H R; Whitfield A J; van Bockxmeer F M
ATP-binding cassette transporter G8 gene as a determinant of apolipoprotein B-100 kinetics in overweight men.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(11):2188-91.
2004: Knuiman Matthew W; Watts Gerald F; Divitini Mark L
Is sialic acid an independent risk factor for cardiovascular disease? A 17-year follow-up study in Busselton, Western Australia.
Annals of epidemiology 2004;14(9):627-32.
2004: Chan Dick C; Barrett P Hugh R; Watts Gerald F
Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods.
Clinical science (London, England : 1979) 2004;107(3):233-49.
2004: Chan Dick C; Barrett P Hugh R; Watts Gerald F
Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies.
Clinical science (London, England : 1979) 2004;107(3):221-32.
2004: Chew G T; Watts G F
Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'.
QJM : monthly journal of the Association of Physicians 2004;97(8):537-48.
2004: Chan Dick C; Barrett P Hugh R; Watts Gerald F
Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies.
The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists 2004;25(1):31-48.
2004: Chan Dick C; Barrett Hugh P R; Watts Gerald F
Dyslipidemia in visceral obesity: mechanisms, implications, and therapy.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2004;4(4):227-46.
2003: Watts Gerald F; Marwick Thomas H
Ventricular dysfunction in early diabetic heart disease: detection, mechanisms and significance.
Clinical science (London, England : 1979) 2003;105(5):537-40.
2003: Dane-Stewart Cheryl A; Watts Gerald F; Pal Sebely; Chan Dick; Thompson Peter; Hung Joseph; Mamo John C l
Effect of atorvastatin on apolipoprotein B48 metabolism and low-density lipoprotein receptor activity in normolipidemic patients with coronary artery disease.
Metabolism: clinical and experimental 2003;52(10):1279-86.
2003: Walsh Jennifer H; Yong Gerald; Cheetham Craig; Watts Gerald F; O'Driscoll Gerard J; Taylor Roger R; Green Daniel J
Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects.
European heart journal 2003;24(18):1681-9.
2003: Watts G F; Chan D C; Barrett P H R; O'Neill F H; Thompson G R
Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2003;27(7):862-5.
2003: Pal Sebely; Semorine Kishore; Watts Gerald F; Mamo John
Identification of lipoproteins of intestinal origin in human atherosclerotic plaque.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(6):792-5.
2003: Chan D C; Watts G F; Barrett P H R; Burke V
Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men.
QJM : monthly journal of the Association of Physicians 2003;96(6):441-7.
2003: Woodman Richard J; Watts Gerald F
Measurement and application of arterial stiffness in clinical research: focus on new methodologies and diabetes mellitus.
Medical science monitor : international medical journal of experimental and clinical research 2003;9(5):RA81-9.
2003: Playford David A; Watts Gerald F; Croft Kevin D; Burke Valerie
Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes.
Atherosclerosis 2003;168(1):169-79.
2003: Chan D C; Watts G F; Barrett P H R
Comparison of intraperitoneal and posterior subcutaneous abdominal adipose tissue compartments as predictors of VLDL apolipoprotein B-100 kinetics in overweight/obese men.
Diabetes, obesity & metabolism 2003;5(3):202-6.
2003: Chan Dick C; Watts Gerald F; Barrett P Hugh R; O'Neill Frans H; Thompson Gilbert R
Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
Obesity research 2003;11(4):591-6.
2003: Chan Dick C; Watts Gerald F; Barrett P Hugh R; O'Neill Frans H; Redgrave Trevor G; Thompson Gilbert R
Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome.
Clinical science (London, England : 1979) 2003;104(4):383-8.
2003: Dane-Stewart C A; Watts G F; Barrett P H R; Stuckey B G A; Mamo J C L; Martins I J; Redgrave T G
Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus.
Clinical endocrinology 2003;58(4):415-20.
2003: Watts Gerald F; Barrett P Hugh R; Ji Juying; Serone Adrian P; Chan Dick C; Croft Kevin D; Loehrer Franziska; Johnson Anthony G
Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Diabetes 2003;52(3):803-11.
2003: James Anthony P; Watts Gerald F; Barrett P Hugh R; Smith Darrin; Pal Sebely; Chan Dick C; Mamo John C L
Effect of weight loss on postprandial lipemia and low-density lipoprotein receptor binding in overweight men.
Metabolism: clinical and experimental 2003;52(2):136-41.
2003: Barrett P Hugh R; Watts Gerald F
Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effects of nutritional interventions.
Current opinion in lipidology 2003;14(1):61-8.
2003: Chan Dick C; Watts Gerald F; Mori Trevor A; Barrett P Hugh R; Redgrave Trevor G; Beilin Lawrence J
Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
The American journal of clinical nutrition 2003;77(2):300-7.
2003: Zilkens Renate R; Rich Lisa; Burke Valerie; Beilin Lawrence J; Watts Gerald F; Puddey Ian B
Effects of alcohol intake on endothelial function in men: a randomized controlled trial.
Journal of hypertension 2003;21(1):97-103.
2003: Watts Gerald F; Chan Dick C; Barrett P Hugh R; Susekov Andrei V; Hua Jianmin; Song Swithin
Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men.
Obesity research 2003;11(1):152-9.
2003: Woodman Richard J; Mori Trevor A; Burke Valerie; Puddey Ian B; Barden Anne; Watts Gerald F; Beilin Lawrence J
Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients.
Atherosclerosis 2003;166(1):85-93.
2002: Dogra Gursharan K; Herrmann Susan; Irish Ashley B; Thomas Mark A B; Watts Gerald F
Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(12):2220-5.
2002: Playford David A; Watts Gerald F; Best James D; Burke Valerie
Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus.
The American journal of cardiology 2002;90(11):1254-7.
2002: Watts Gerald F
The Yin and Yang of cholesteryl ester transfer protein and atherosclerosis.
Clinical science (London, England : 1979) 2002;103(6):595-7.
2002: Hodgson J M; Watts G F; Playford D A; Burke V; Croft K D
Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes.
European journal of clinical nutrition 2002;56(11):1137-42.
2002: Woodman Richard J; Mori Trevor A; Burke Valerie; Puddey Ian B; Watts Gerald F; Beilin Lawrence J
Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
The American journal of clinical nutrition 2002;76(5):1007-15.
2002: Watts Gerald F; Chan Dick C; Barrett P Hugh R
Adipose tissue compartments and the kinetics of very-low-density lipoprotein apolipoprotein B-100 in non-obese men.
Metabolism: clinical and experimental 2002;51(9):1206-10.
2002: Chan Dick C; Watts Gerald F; Redgrave Trevor G; Mori Trevor A; Barrett P Hugh R
Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
Metabolism: clinical and experimental 2002;51(8):1041-6.
2002: Chan Dick C; Watts Gerald F; Barrett P Hugh R; Beilin Lawrence J; Redgrave Trevor G; Mori Trevor A
Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.
Diabetes 2002;51(8):2377-86.
2002: Dogra Gursharan K; Watts Gerald F; Herrmann Susan; Thomas Mark A B; Irish Ashley B
Statin therapy improves brachial artery endothelial function in nephrotic syndrome.
Kidney international 2002;62(2):550-7.
2002: Dane-Stewart C A; Watts G F; Mamo J C L; Barrett P H R; Martins I J; Dimmitt S B; Redgrave T G
Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia.
European journal of clinical investigation 2002;32(7):493-9.
2002: Woodman Richard J; Watts Gerald F; Puddey Ian B; Burke Valerie; Mori Trevor A; Hodgson Jonathan M; Beilin Lawrence J
Leukocyte count and vascular function in Type 2 diabetic subjects with treated hypertension.
Atherosclerosis 2002;163(1):175-81.
2002: Chan D C; Watts G F; Mori T A; Barrett P H R; Beilin L J; Redgrave T G
Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity.
European journal of clinical investigation 2002;32(6):429-36.
2002: Chan Dick C; Watts Gerald F; Barrett P Hugh R; Beilin Lawrence J; Mori Trevor A
Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity.
Clinical chemistry 2002;48(6 Pt 1):877-83.
2002: Chan Dick C; Watts Gerald F; Barrett P Hugh R; Mori Trevor A; Beilin Lawrence J; Redgrave Trevor G
Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity.
The Journal of clinical endocrinology and metabolism 2002;87(5):2283-9.
2002: Chan Dick C; Watts Gerald F; Barrett P Hugh R; Martins Ian J; James Anthony P; Mamo John C L; Mori Trevor A; Redgrave Trevor G
Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test.
Journal of lipid research 2002;43(5):706-12.
2002: Watts G F; Playford D A; Croft K D; Ward N C; Mori T A; Burke V
Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.
Diabetologia 2002;45(3):420-6.
2002: Watts G F; Barrett P H
High-density lipoprotein metabolism in familial hypercholesterolaemia: significance, mechanisms, therapy.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2002;12(1):36-41.
2002: Dwyer Kevin P; Barrett P Hugh R; Chan Dick; Foo Jock I; Watts Gerald F; Croft Kevin D
Oxazolinone derivative of leucine for GC-MS: a sensitive and robust method for stable isotope kinetic studies of lipoproteins.
Journal of lipid research 2002;43(2):344-9.
2002: Hodgson Jonathan M; Puddey Ian B; Burke Valerie; Watts Gerald F; Beilin Lawrence J
Regular ingestion of black tea improves brachial artery vasodilator function.
Clinical science (London, England : 1979) 2002;102(2):195-201.
2002: Chan Dick C; Watts Gerald F; Barrett P Hugh; Mamo John C L; Redgrave Trevor G
Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity.
Clinical chemistry 2002;48(2):278-83.
2001: Watts G F; Chan D C; Barrett P H; Martins I J; Redgrave T G
Preliminary experience with a new stable isotope breath test for chylomicron remnant metabolism: a study in central obesity.
Clinical science (London, England : 1979) 2001;101(6):683-90.
2001: Mamo J C; Watts G F; Barrett P H; Smith D; James A P; Pal S
Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?
American journal of physiology. Endocrinology and metabolism 2001;281(3):E626-32.
2001: Dogra G; Irish A B; Watts G F
Homocysteine and nephrotic syndrome.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(8):1720-1.
2001: Dogra G; Ward N; Croft K D; Mori T A; Barrett P H; Herrmann S E; Irish A B; Watts G F
Oxidant stress in nephrotic syndrome: comparison of F(2)-isoprostanes and plasma antioxidant potential.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(8):1626-30.
2001: Watts G F; Barrett P H; Marais A D; Dane-Stewart C A; Martins I J; Dimmitt S B; Redgrave T G
Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test.
Atherosclerosis 2001;157(2):519-23.
2001: Woodman R J; Playford D A; Watts G F; Cheetham C; Reed C; Taylor R R; Puddey I B; Beilin L J; Burke V; Mori T A; Green D
Improved analysis of brachial artery ultrasound using a novel edge-detection software system.
Journal of applied physiology (Bethesda, Md. : 1985) 2001;91(2):929-37.
2001: Watts G F; Herrmann S; Dogra G K; Playford D A; Best J D; Thomas M A; Irish A
Vascular function of the peripheral circulation in patients with nephrosis.
Kidney international 2001;60(1):182-9.
2001: Burnett J R; Watts G F
Therapeutic considerations for postprandial dyslipidaemia.
Diabetes, obesity & metabolism 2001;3(3):143-56.
2001: Dogra G; Rich L; Stanton K; Watts G F
Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria.
Diabetologia 2001;44(5):593-601.
2001: Redgrave T G; Watts G F; Martins I J; Barrett P H; Mamo J C; Dimmitt S B; Marais A D
Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
Journal of lipid research 2001;42(5):710-5.
2001: Burnett J R; Moses E A; Croft K D; Brown A J; Grainger K; Vasikaran S D; Leitersdorf E; Watts G F
Clinical and biochemical features, molecular diagnosis and long-term management of a case of cerebrotendinous xanthomatosis.
Clinica chimica acta; international journal of clinical chemistry 2001;306(1-2):63-9.
2001: Dane-Stewart C A; Watts G F; Mamo J C; Dimmitt S B; Barrett P H; Redgrave T G
Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia.
European journal of clinical investigation 2001;31(2):113-7.
2000: Watts G F; Moroz P; Barrett P H
Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable-isotope studies.
Metabolism: clinical and experimental 2000;49(9):1204-10.
2000: Mori T A; Watts G F; Burke V; Hilme E; Puddey I B; Beilin L J
Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men.
Circulation 2000;102(11):1264-9.
2000: Mori T A; Burke V; Puddey I B; Watts G F; O'Neal D N; Best J D; Beilin L J
Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.
The American journal of clinical nutrition 2000;71(5):1085-94.
2000: Watts G F; Herrmann S; Riches F M
Effects of diet and serotonergic agonist on hepatic apolipoprotein B-100 secretion and endothelial function in obese men.
QJM : monthly journal of the Association of Physicians 2000;93(3):153-61.
2000: Watts G F; Riches F M; Humphries S E; Talmud P J; van Bockxmeer F M
Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity.
Journal of lipid research 2000;41(3):481-8.
2000: Watts G F
Postprandial lipaemia in familial hypercholesterolaemia: clinical and metabolic significance.
Atherosclerosis 2000;148(2):426-8.
1999: Watts G F; Dimmitt S B
Fibrates, dyslipoproteinaemia and cardiovascular disease.
Current opinion in lipidology 1999;10(6):561-74.
1999: Mori T A; Bao D Q; Burke V; Puddey I B; Watts G F; Beilin L J
Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects.
The American journal of clinical nutrition 1999;70(5):817-25.
1999: Playford D; Watts G F
Endothelial dysfunction, insulin resistance and diabetes: exploring the web of causality.
Australian and New Zealand journal of medicine 1999;29(4):523-34.
1999: Riches F M; Watts G F; Hua J; Stewart G R; Naoumova R P; Barrett P H
Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men.
The Journal of clinical endocrinology and metabolism 1999;84(8):2854-61.
1999: Smith D; Watts G F; Dane-Stewart C; Mamo J C
Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state.
European journal of clinical investigation 1999;29(3):204-9.
1998: Watts G F; Mamo J C; Redgrave T G
Postprandial dyslipidaemia in a nutshell: food for thought.
Australian and New Zealand journal of medicine 1998;28(6):816-23.
1998: Watts G F; Playford D A
Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis.
Atherosclerosis 1998;141(1):17-30.
1998: Riches F M; Watts G F; van Bockxmeer F M; Hua J; Song S; Humphries S E; Talmud P J
Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men.
Journal of lipid research 1998;39(9):1752-8.
1998: Playford D A; Watts G F
Special article: non-invasive measurement of endothelial function.
Clinical and experimental pharmacology & physiology 1998;25(7-8):640-3.
1998: Riches F M; Watts G F; Naoumova R P; Kelly J M; Croft K D; Thompson G R
Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(5):414-23.
1997: O'Brien S F; Watts G F; Playford D A; Burke V; O'Neal D N; Best J D
Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1997;14(11):974-8.
1997: Riches F M; Watts G F; Naoumova R P; Kelly J M; Croft K D; Thompson G R
Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man.
Atherosclerosis 1997;135(1):83-91.
1997: Watts G F; Naoumova R P; Kelly J M; Riches F M; Croft K D; Thompson G R
Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects.
The American journal of physiology 1997;273(3 Pt 1):E462-70.
1997: Watts G F; Riches F M; Kelly J M; Powell M A; Croft K D
Determinants of the kinetics of very low-density lipoprotein apolipoprotein B-100 in non-obese men.
Clinical and experimental pharmacology & physiology 1997;24(8):556-62.
1997: Playford D A; Watts G F
Management of lipid disorders in the elderly.
Drugs & aging 1997;10(6):444-62.
1997: O'Brien S F; Powrie J K; Watts G F
Comparison of urinary albumin, retinol-binding protein and N-acetyl beta-glucosaminidase as predictors of progression of low level albuminuria in diabetes.
Annals of clinical biochemistry 1997;34 ( Pt 2)():202-4.
1996: Watts G F; O'Brien S F; Silvester W; Millar J A
Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia.
Clinical science (London, England : 1979) 1996;91(5):567-73.
1996: Watts G F; Powrie J K; O'Brien S F; Shaw K M
Apolipoprotein B independently predicts progression of very-low-level albuminuria in insulin-dependent diabetes mellitus.
Metabolism: clinical and experimental 1996;45(9):1101-7.
1996: Koukkou E; Watts G F; Lowy C
Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study.
Journal of clinical pathology 1996;49(8):634-7.
1996: Watts G F; Jackson P; Burke V; Lewis B
Dietary fatty acids and progression of coronary artery disease in men.
The American journal of clinical nutrition 1996;64(2):202-9.
1996: Watts G F; O'Brien S F; Shaw K M
Urinary infection and albumin excretion in insulin-dependent diabetes mellitus: implications for the measurement of microalbuminuria.
Diabetic medicine : a journal of the British Diabetic Association 1996;13(6):520-4.
1996: O'Brien S F; Watts G F; Powrie J K; Shaw K M; Miller N J
Lipids, lipoproteins, antioxidants and glomerular and tubular dysfunction in type 1 diabetes.
Diabetes research and clinical practice 1996;32(1-2):81-90.
1996: Naoumova R P; Cummings M H; Watts G F; Rendell N B; Taylor G W; Sönksen P H; Thompson G R
Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects.
European journal of clinical investigation 1996;26(4):332-40.
1996: Thompson G R; Naoumova R P; Watts G F
Role of cholesterol in regulating apolipoprotein B secretion by the liver.
Journal of lipid research 1996;37(3):439-47.
1996: Powrie J K; Watts G F; Crook M A; Ingham J N; Taub N A; Shaw K M
Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1996;13(3):238-42.
1996: Watts G F; Mitchell W D; Bending J J; Reshef A; Leitersdorf E
Cerebrotendinous xanthomatosis: a family study of sterol 27-hydroxylase mutations and pharmacotherapy.
QJM : monthly journal of the Association of Physicians 1996;89(1):55-63.
1995: O'Brien S F; Watts G F; Powrie J K; Shaw K M
Exercise testing as a long-term predictor of the development of microalbuminuria in normoalbuminuric IDDM patients.
Diabetes care 1995;18(12):1602-5.
1995: Watts G F; Lewis B; Jackson P; Burke V; Lewis E S; Brunt J N; Coltart D J
Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography.
The Canadian journal of cardiology 1995;11 Suppl G():110G-114G.
1995: Cummings M H; Watts G F; Umpleby A M; Hennessy T R; Kelly J M; Jackson N C; Sönksen P H
Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
Diabetes 1995;44(9):1059-65.
1995: Watts G F; Naoumova R; Cummings M H; Umpleby A M; Slavin B M; Sönksen P H; Thompson G R
Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects.
Metabolism: clinical and experimental 1995;44(8):1052-7.
1995: Cummings M H; Watts G F; Umpleby A M; Hennessy T R; Naoumova R; Slavin B M; Thompson G R; Sönksen P H
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
Diabetologia 1995;38(8):959-67.
1995: Watts G F; Cummings M H; Umpleby M; Quiney J R; Naoumova R; Thompson G R; Sönksen P H
Simvastatin decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications.
European journal of clinical investigation 1995;25(8):559-67.
1995: Watts G F; Mazurkiewicz J C; Tonge K; Nelson V; Warburton F G; Slavin B M
Lipoprotein(a) as a determinant of the severity of angiographically defined carotid atherosclerosis.
QJM : monthly journal of the Association of Physicians 1995;88(5):321-6.
1995: Watts G F
Familial Hypercholesterolaemia Regression Study and its implications.
Lancet 1995;345(8953):807-8.
1995: Talmud P J; Watts G F; McBride S; Mandalia S; Brunt J N; Coltart D J; Lewis B; Humphries S E
Angiotensin converting enzyme gene polymorphism and the course of angiographically defined coronary artery disease.
Atherosclerosis 1995;114(1):133-5.
1995: Watts G F; Crook M A; Haq S; Mandalia S
Serum sialic acid as an indicator of change in coronary artery disease.
Metabolism: clinical and experimental 1995;44(2):147-8.
1995: Cummings M H; Watts G F; Umpleby M; Hennessy T R; Quiney J R; Sönksen P H
Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
Atherosclerosis 1995;113(1):79-89.
1995: Watts G F; ap Gwilym R M; Mazurkiewicz J; Coltart J
Independent correlation between plasma lipoprotein(a) and angiographic coronary artery disease in NIDDM.
Diabetes care 1995;18(2):234-6.
1995: Cummings M H; Watts G F; Pal C; Umpleby M; Hennessy T R; Naoumova R; Sönksen P H
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in obesity: a stable isotope study.
Clinical science (London, England : 1979) 1995;88(2):225-33.
1995: Cummings M H; Watts G F
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesteryl ester storage disease.
Clinical chemistry 1995;41(1):111-4.
1995: Watts G F
Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group.
Journal of cardiovascular pharmacology 1995;25 Suppl 4():S11-9.
1994: Watts G F; Mandalia S; Slavin B M; Brunt J N; Coltart D J; Lewis B
Metabolic determinants of the course of coronary artery disease in men.
Clinical chemistry 1994;40(12):2240-6.
1994: Koukkou E; Watts G F; Mazurkiewicz J; Lowy C
Ethnic differences in lipid and lipoprotein metabolism in pregnant women of African and Caucasian origin.
Journal of clinical pathology 1994;47(12):1105-7.
1994: Russell-Jones D L; Watts G F; Weissberger A; Naoumova R; Myers J; Thompson G R; Sönksen P H
The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients.
Clinical endocrinology 1994;41(3):345-50.
1994: Mazurkiewicz J C; Watts G F; Warburton F G; Slavin B M; Lowy C; Koukkou E
Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients.
Journal of clinical pathology 1994;47(8):728-31.
1994: Cummings M H; Watts G F
Drug treatment of hypercholesterolaemia in a patient with Gilbert's syndrome.
Annals of clinical biochemistry 1994;31 ( Pt 4)():383-5.
1994: Chowienczyk P J; Watts G F; Cockcroft J R; Brett S E; Ritter J M
Sex differences in endothelial function in normal and hypercholesterolaemic subjects.
Lancet 1994;344(8918):305-6.
1994: Cummings M H; Watts G F; Lumb P J; Slavin B M
Comparison of immunoturbidimetric and Lowry methods for measuring concentration of very low density lipoprotein apolipoprotein B-100 in plasma.
Journal of clinical pathology 1994;47(2):176-8.
1994: Powrie J K; Watts G F; Smith G D; Sönksen P H; Jones R H
Short-term effects of mepacrine on serum lipids, lipoproteins, and apolipoproteins in patients with non-insulin-dependent diabetes mellitus.
Metabolism: clinical and experimental 1994;43(2):131-4.
1994: Watts G F; Jackson P; Mandalia S; Brunt J N; Lewis E S; Coltart D J; Lewis B
Nutrient intake and progression of coronary artery disease.
The American journal of cardiology 1994;73(5):328-32.
1993: Watts G F; Castelluccio C; Rice-Evans C; Taub N A; Baum H; Quinn P J
Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin.
Journal of clinical pathology 1993;46(11):1055-7.
1993: Watts G F; Mandalia S; Brunt J N; Slavin B M; Coltart D J; Lewis B
Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS).
Metabolism: clinical and experimental 1993;42(11):1461-7.
1993: Watts G F; Taub N A; Mazurkiewicz J; Shaw K M
An examination of the covariability of subclinical albuminuria in insulin-dependent diabetes mellitus: implications for monitoring microalbuminuria.
Diabetes research and clinical practice 1993;21(2-3):177-85.
1993: Powrie J K; Shojaee-Moradie F; Watts G F; Smith G D; Sönksen P H; Jones R H
Effects of chloroquine on the dyslipidemia of non-insulin-dependent diabetes mellitus.
Metabolism: clinical and experimental 1993;42(4):415-9.
1993: Watts G F; Kearney E M; Taub N A; Slavin B M
Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia.
Journal of clinical pathology 1993;46(3):267-70.
1992: Chowienczyk P J; Watts G F; Cockcroft J R; Ritter J M
Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia.
Lancet 1992;340(8833):1430-2.
1992: Lehmann E D; Watts G F; Fatemi-Langroudi B; Gosling R G
Aortic compliance in young patients with heterozygous familial hypercholesterolaemia.
Clinical science (London, England : 1979) 1992;83(6):717-21.
1992: Quiney J; Watts G F; Kerr-Muir M; Slavin B; Lewis B
One year experience in the treatment of familial hypercholesterolaemia with simvastatin.
Postgraduate medical journal 1992;68(801):575-80.
1992: Watts G F; Mitchell W D
Clinical and metabolic findings in a patient with phytosterolaemia.
Annals of clinical biochemistry 1992;29 ( Pt 2)():231-6.
1992: Watts G F; Lewis B; Brunt J N; Lewis E S; Coltart D J; Smith L D; Mann J I; Swan A V
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
Lancet 1992;339(8793):563-9.
1992: Watts G F; Morton K; Jackson P; Lewis B
Management of patients with severe hypertriglyceridaemia during pregnancy: report of two cases with familial lipoprotein lipase deficiency.
British journal of obstetrics and gynaecology 1992;99(2):163-6.
1991: Watts G F; Cameron J; Henderson A; Richmond W
Lipoprotein lipase deficiency due to long-term heparinization presenting as severe hypertriglyceridaemia in pregnancy.
Postgraduate medical journal 1991;67(794):1062-4.
1991: Watts G F; Macleod A F; Benn J J; Slavin B M; Morris R W; Williams C D; Kearney E M; Lowy C; Sönksen P H
Comparison of the real-time use of glycosylated haemoglobin and plasma fructosamine in the diabetic clinic.
Diabetic medicine : a journal of the British Diabetic Association 1991;8(6):573-9.
1991: Watts G F; Harris R; Shaw K M
The determinants of early nephropathy in insulin-dependent diabetes mellitus: a prospective study based on the urinary excretion of albumin.
The Quarterly journal of medicine 1991;79(288):365-78.
1990: Watts G F; Pillay D; Kind P R
Influence of atenolol on within-subject variation of thyroid function tests.
Annals of clinical biochemistry 1990;27 ( Pt 6)():599-600.
1990: Watts G F; Kubal C; Chinn S
Long-term variation of urinary albumin excretion in insulin-dependent diabetes mellitus: some practical recommendations for monitoring microalbuminuria.
Diabetes research and clinical practice 1990;9(2):169-77.
1990: Watts G F; Pillay D
Effect of ketones and glucose on the estimation of urinary creatinine: implications for microalbuminuria screening.
Diabetic medicine : a journal of the British Diabetic Association 1990;7(3):263-5.
1989: Watts G F; Williams I; Morris R W; Mandalia S; Shaw K M; Polak A
An acceptable exercise test to study microalbuminuria in type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1989;6(9):787-92.
1989: Ruys T; Sturgess I; Shaikh M; Watts G F; Nordestgaard B G; Lewis B
Effects of exercise and fat ingestion on high density lipoprotein production by peripheral tissues.
Lancet 1989;2(8672):1119-22.
1989: Watts G F; Powell M; Rowe D J; Shaw K M
Low-molecular-weight proteinuria in insulin-dependent diabetes mellitus: a study of the urinary excretion of beta 2-microglobulin and retinol-binding protein in alkalinized patients with and without microalbuminuria.
Diabetes research (Edinburgh, Scotland) 1989;12(1):31-6.
1989: Watts G F; Naumova R; Slavin B M; Morris R W; Houlston R; Kubal C; Shaw K M
Serum lipids and lipoproteins in insulin-dependent diabetic patients with persistent microalbuminuria.
Diabetic medicine : a journal of the British Diabetic Association 1989;6(1):25-30.
1988: Watts G F; Gregory L; Naoumova R; Kubal C; Shaw K M
Nutrient intake in insulin-dependent diabetic patients with incipient nephropathy.
European journal of clinical nutrition 1988;42(8):697-702.
1987: Kearney E M; Mount J N; Watts G F; Slavin B M; Kind P R
Simple immunoturbidimetric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyser.
Journal of clinical pathology 1987;40(4):465-8.
1986: Watts G F; Bennett J E; Rowe D J; Morris R W; Gatling W; Shaw K M; Polak A
Assessment of immunochemical methods for determining low concentrations of albumin in urine.
Clinical chemistry 1986;32(8):1544-8.

Sign-in to see more